did not achieve significanceP = 0.30
Response rates with secukinumab 150 mg without loading dose were numerically higher than with placebo but did not achieve significance (23.5% [ P = 0.30]).
← all excerpts
Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies.
1
0.3000
0.3000